Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03091192
What this trial is testing

Savolitinib vs. Sunitinib in MET-driven PRCC.

Who this might be right for
CarcinomaCarcinoma, Renal CellKidney Neoplasms+5 more
AstraZeneca 60
Very early researchWithdrawnNCT06708936
What this trial is testing

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Who this might be right for
Clear Cell Renal Cell Carcinoma (ccRCC)
Kousai Bio Co., Ltd.
Not applicableEnded earlyNCT01073644
What this trial is testing

Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05411081
What this trial is testing

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

Who this might be right for
Metastatic Papillary Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
National Cancer Institute (NCI) 200
Early research (Phase 1)Study completedNCT01826877
What this trial is testing

Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
Jonsson Comprehensive Cancer Center 12
Early research (Phase 1)Study completedNCT02219711
What this trial is testing

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 193
Testing effectiveness (Phase 2)Looking for participantsNCT04974671
What this trial is testing

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaOligoprogressive+1 more
Yale University 30
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Early research (Phase 1)UnknownNCT00006431
What this trial is testing

Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA

Who this might be right for
Renal Cell Carcinoma
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Study completedNCT01550367
What this trial is testing

Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

Who this might be right for
Metastatic Renal Cell Carcinoma
Leonard Appleman 30
Not applicableLooking for participantsNCT07240610
What this trial is testing

Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Cancer Metastatic
Zhe Chen 145
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)WithdrawnNCT03111901
What this trial is testing

Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer

Who this might be right for
Carcinoma, Renal CellMelanoma
William Grosh, MD
Not applicableLooking for participantsNCT06525831
What this trial is testing

Rein 3D PRINT MECHANICS

Who this might be right for
Kidney Cancer
University Hospital, Bordeaux 50
Not applicableStudy completedNCT03916458
What this trial is testing

REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Who this might be right for
Carcinoma, Renal Cell
Pfizer 62
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00112840
What this trial is testing

CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT00934440
What this trial is testing

Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas Medical Center 11
Early research (Phase 1)Study completedNCT01358721
What this trial is testing

Phase I Biomarker Study (BMS-936558)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 119
Not applicableStudy completedNCT02864615
What this trial is testing

Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy

Who this might be right for
Metastatic Renal Cell Carcinoma
Kidney Cancer Research Bureau 17
Next Page